A Randomized, Double-Blinded, Phase II Study of Maintenance Pembrolizumab versus Placebo after First-line Chemotherapy in Patients with Metastatic Urothelial Cancer

Type of Cancer
Genito-Urinary

Site
Hackensack

Sponsor
Hoosier

Protocol Number
GU14-182

To Learn More Call
201-510-0910